Collaboration agreement between Cell2Cure and Cbio A/S

Cell2Cure has entered a collaboration agreement with Cbio A/S to establish Cell2Cure’s own GMP facility for production of adipose tissue-derived mesenchymal stromal/stem cell products (ASCs) in Cbio’s newly established and approved cell production facility, Transformervej 8, 2860 Søborg, Denmark.

Cell2cure has a license from Rigshospitalet, Copenhagen, to a proprietary ASC production technology platform.

C2C will in these new facilities further develop ASC product portfolio and continue clinical development programs for diseases with inflammatory, immunological and tissue/function re-generation components involved.